BioCryst Pharmaceuticals
BCRX
BCRX
123 hedge funds and large institutions have $938M invested in BioCryst Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9% less call options, than puts
Call options by funds: $9.82M | Put options by funds: $10.8M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
123
Holding in Top 10
3
Calls
$9.82M
Puts
$10.8M
Top Buyers
| 1 | +$16.4M | |
| 2 | +$11.3M | |
| 3 | +$11.2M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$8.18M |
| 5 |
PA
Perceptive Advisors
New York
|
+$7.02M |
Top Sellers
| 1 | -$64.5M | |
| 2 | -$20.5M | |
| 3 | -$18M | |
| 4 |
Millennium Management
New York
|
-$7.68M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$3.08M |